Teacher Retirement System of Texas Purchases New Shares in Amedisys, Inc. (NASDAQ:AMED)

Teacher Retirement System of Texas bought a new stake in Amedisys, Inc. (NASDAQ:AMED) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,816 shares of the health services provider’s stock, valued at approximately $817,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AMED. Vanguard Group Inc. grew its position in shares of Amedisys by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 3,216,120 shares of the health services provider’s stock worth $291,992,000 after buying an additional 10,817 shares during the period. Pentwater Capital Management LP grew its position in shares of Amedisys by 178.3% in the 4th quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider’s stock valued at $107,132,000 after purchasing an additional 756,000 shares during the period. Norges Bank acquired a new position in Amedisys in the 4th quarter worth $83,061,000. Alliancebernstein L.P. boosted its position in shares of Amedisys by 2.0% during the fourth quarter. Alliancebernstein L.P. now owns 677,787 shares of the health services provider’s stock worth $61,536,000 after buying an additional 13,587 shares during the period. Finally, Magnetar Financial LLC boosted its position in shares of Amedisys by 0.3% during the fourth quarter. Magnetar Financial LLC now owns 637,443 shares of the health services provider’s stock worth $57,873,000 after buying an additional 1,835 shares during the period. Institutional investors and hedge funds own 94.36% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on AMED. Royal Bank Of Canada restated an “outperform” rating and set a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Wall Street Zen cut shares of Amedisys from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 24th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $100.75.

Amedisys Stock Up 0.6%

AMED stock opened at $97.79 on Tuesday. The business has a 50-day simple moving average of $95.84 and a 200 day simple moving average of $93.53. The company has a market cap of $3.21 billion, a PE ratio of 36.08, a price-to-earnings-growth ratio of 1.32 and a beta of 0.94. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95.

Amedisys (NASDAQ:AMED) last released its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.13 by $0.12. The business had revenue of $594.78 million during the quarter, compared to analysts’ expectations of $597.43 million. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.03 EPS. Sell-side analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.